Broker tips
Spread Betting and CFD trading carry a high level of risk to your capital; you should ensure you understand the risks involved. Please read the full risk warning.
-
Broker tips: BT, Misys, GAME
03 Feb, 2012 11:27
Nomura has maintained its buy rating on BT, saying that the telecom titan's trading momentum is building nicely for 2012. -
Broker snap: Sell Misys, says Merchant Securities
03 Feb, 2012 11:23
Merchant Securities has given financial software provider Misys a sell rating following the news that the firm is in talks with a suitor. -
Broker snap: Peel Hunt keeps hold of GAME
03 Feb, 2012 11:15
Shares in struggling computer gaming retailer GAME Group surged on Friday morning after it confirmed revised terms have been agreed with its lenders, but Peel Hunt has maintained its cautious stance on the stock. -
Friday broker round-up - UPDATE
03 Feb, 2012 09:55
Royal Bank of Scotland: Deutsche Bank downgrades to hold from buy. -
Broker snap: BT building momentum, says Nomura
03 Feb, 2012 09:31
Nomura has maintained its buy rating on BT, saying that the telecom titan's trading momentum is building nicely for 2012. -
Broker tips: AstraZeneca, Kazakhmys, Imperial Tobacco
02 Feb, 2012 11:16
Panmure Gordon has reiterated its buy recommendation for drugs giant AstraZeneca after the group's fourth quarter results came broadly in line with forecasts. -
Broker snap: Kazakhmys a sector standout, says Galvan
02 Feb, 2012 11:14
Galvan Research and Trading has labelled copper mining giant Kazakhmys as a buy after the firm met all of its major output targets in 2011. -
Broker snap: Nomura upgrades Imperial on M&A prospects
02 Feb, 2012 10:45
Nomura has upgraded Imperial Tobacco from reduce to neutral, saying that a focus on operational pressures has shifted to the prospect of M&A. -
Broker snap: Panmure remains a buyer of AstraZeneca
02 Feb, 2012 10:15
Panmure Gordon has reiterated its buy recommendation for drugs giant AstraZeneca after the group's fourth quarter results came broadly in line with forecasts. -
Thursday broker round-up
02 Feb, 2012 09:15
AstraZeneca: Panmure Gordon maintains buy rating and 3,600p target.
iPhone Log In
Market latest
| FTSE 100 | 5,901.07 | +1.78% | |
| FTSE 250 | 11,235.15 | +1.32% | |
| FTSE All Share | 3,047.42 | +1.70% | |
| Dow Jones | 12,862.23 | +1.22% | |
| NASDAQ | 2,905.66 | +1.58% | |
| Nikkei | 8,924.98 | +1.05% | |
| Hang Seng | 20,889.12 | +0.64% |
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
Index